Alteration of serum miR-206 and miR-133b is associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

被引:39
|
作者
Wu, Jianjun [1 ]
Yang, Ti [1 ]
Li, Xun [1 ]
Yang, Qiaoyuan [1 ]
Liu, Rong [1 ,2 ]
Huang, Jinkun [1 ,2 ]
Li, Yuanqi [1 ]
Yang, Chengfeng [3 ,4 ]
Jiang, Yiguo [1 ]
机构
[1] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou 510182, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Guangzhou 510120, Guangdong, Peoples R China
[3] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA
[4] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA
基金
中国国家自然科学基金;
关键词
Serum; miR-206; miR-133b; Lung carcinogenesis; 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone; MICRORNA EXPRESSION; MALIGNANT-TRANSFORMATION; CIRCULATING MICRORNAS; F344; RATS; BIOMARKERS; TUMORIGENESIS; BIOCHEMISTRY; SIGNATURES; CIGARETTE; INVASION;
D O I
10.1016/j.taap.2013.01.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The alteration of microRNA (miRNA) expression plays an important role in chemical carcinogenesis. Presently, few reports have been published that concern the significance of circulating miRNAs in lung carcinogenesis induced by environmental carcinogens. The purpose of this study was to identify serum miRNAs that could be associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Male F344 rats were systemically administered with NNK. The rat serum differential expression profiles of miRNAs were analyzed by small RNA solexa sequencing. Using quantitative real-time PCR, the differentially expressed serum miRNAs were identified in each individual rat. Serum miR-206 and miR-133b were selected for further identification in rat serum at different stages of lung carcinogenesis; we detected the levels of serum miR-206 and miR-133b in lung cancer tissues induced by NNK. NNK causes significant alteration of serum miRNA expression. Compared to the control group, serum miR-206 and miR-133b were significantly up-regulated in the early stage of NNK-induced lung carcinogenesis. miR-206 and miR-133b exhibited low-expression in lung cancer tissues. Our results demonstrate that lung carcinogen NNK exposure changes the expression of serum miRNAs. Serum miR-206 and miR-133b could be associated with lung carcinogenesis induced by NNK. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:238 / 246
页数:9
相关论文
共 50 条
  • [21] Effects of quercetin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolizing enzymes in rat lung
    Liu, Ying-Hui
    Peng, Ren-Xiu
    Wu, Jun-Yu
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 383 - 383
  • [22] Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers
    Meger, M
    MegerKossien, I
    Dietrich, M
    Scherer, G
    Adlkofer, F
    Tricker, AR
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 : 155 - 155
  • [23] Formation and stability of 4-(hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronide, a stable form of reactive intermediate produced from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in mice
    Nishiyama, Takahito
    Hayashi, Nahoko
    Kakurai, Naoki
    Yanagita, Hiromi
    Kuriyama, Ai
    Miyamoto, Chika
    Ishihara, Yumi
    Ogura, Kenichiro
    Ohnuma, Tomokazu
    Hiratsuka, Akira
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (04): : 515 - 521
  • [24] Tissue distributions of 4-(hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronide, a stable form of reactive intermediate produced from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in the rat
    Nishiyama, Takahito
    Ogura, Kenichiro
    Ohnuma, Tomokazu
    Hiratsuka, Akira
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (02): : 263 - 267
  • [25] Identification of 4-(methylnitroamino)-1-(3-pyridyl-1-oxide)-1-butanone, a novel metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat urine
    von Weymarn, Linda
    Dator, Romel
    Balbo, Silvia
    Murphy, Sharon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [26] Chemopreventive Role of Apigenin against the Synergistic Carcinogenesis of Human Papillomavirus and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Yin, Fangzheng
    Zhao, Lijiao
    Zhang, Lili
    Chen, Yuhe
    Sun, Guohui
    Li, Jintao
    Zhang, Na
    Xu, Yuancong
    Chan, Paul Kay-Sheung
    Zhong, Rugang
    BIOMEDICINES, 2020, 8 (11) : 1 - 15
  • [27] Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rhesus monkeys
    Meger, M
    Richter, E
    Zwickenpflug, W
    Oehlmann, C
    Hargaden, MB
    A-Rahim, YI
    Vesell, ES
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (04) : 471 - 478
  • [28] Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes
    Collazo, NR
    Sultatos, LG
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) : 1933 - 1941
  • [29] Characterization of human lung enzymes involved in the reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Ashmore, Joseph
    Liu, Ying
    Peterson, Amity
    Fechtner, Sabrina
    Chen, Gang
    Lazarus, Philip
    CANCER RESEARCH, 2015, 75
  • [30] EFFECTS OF SULINDAC AND OLTIPRAZ ON THE TUMORIGENICITY OF 4-(METHYLNITROSAMINO)1-(3-PYRIDYL)-1-BUTANONE IN A/J MOUSE LUNG
    PEPIN, P
    BOUCHARD, L
    NICOLE, P
    CASTONGUAY, A
    CARCINOGENESIS, 1992, 13 (03) : 341 - 348